Balt Group

🎉 Balt Group at the 20km de Paris! 🏃♂️🏅 This past Sunday, the Balt Group team proudly participated in the iconic 20km de Paris. It was an amazing day full of energy, determination, and teamwork as we took on the challenge together. A special shoutout to our colleagues outside of France who ran the race remotely, showing that no matter the distance, we are always united in spirit and driven by the same values. At Balt, we believe that pushing our limits—whether in business or sports—brings out the best in us. Huge congratulations to all the runners and supporters who made this event unforgettable! Go team Balt! Balt USA BALT GERMANY GmbH Balt Spain Medical Balt India Balt Italy #TeamBalt #20kmParis #Teamwork #ChallengeAccepted #BaltGroupe #GlobalTeam #Paris

On Tuesday, October 1, 2024, BALT welcomed 5 new employees to its Montmorency site in France. During this onboarding over a convivial breakfast, the Human Resources team presented the history of Balt, the French flagship in interventional neuroradiology, as well as its activities, mission, values and ambitious projects for the coming years. We are proud to integrate these new experts into our Quality, Regulatory Affairs, R&D/Engineering and Purchasing/Supply Chain teams and we are convinced that they will contribute their skills and know-how to support BALT's challenges and growth. Welcome to our new employees! #employerbrand #attractiveness #employees #humanresources

World Stroke Day is approaching at the end of this month. Do you know how to spot the signs of a stroke and act FAST? Recognizing the symptoms early can make all the difference. Stay informed and help save lives! #WorldStrokeDay #StrokeAwareness #ActFAST

#WFITN2024 #INReporters - “my crazy aneurysm cases” 👉 𝗣𝗿. 𝗣𝗮𝗻𝘁𝗮𝗸𝗮𝗿 remembered us that recurrence is a major drawback of endovascular approach & highlighted the need to progress to be able to reach completer & more stable occlusion using EVT.  He presented complex cases of combination of coils / intrasaccular devices (ISD) / Flow diverters (FD). In some cases, 𝙩𝙝𝙞𝙣𝙠𝙞𝙣𝙜 𝙤𝙪𝙩𝙨𝙞𝙙𝙚 𝙩𝙝𝙚 𝙗𝙤𝙭 𝙘𝙖𝙣 𝙝𝙚𝙡𝙥 𝙩𝙤 𝙢𝙖𝙣𝙖𝙜𝙚 𝙘𝙤𝙢𝙥𝙡𝙚𝙭 𝙘𝙖𝙨𝙚𝙨 & 𝙩𝙤 𝙘𝙪𝙧𝙚 𝙘𝙤𝙢𝙥𝙡𝙚𝙭 𝙖𝙣𝙚𝙪𝙧𝙮𝙨𝙢𝙨. He showed surprising but efficient association as ISD & FD as first line treatment to cure very complex aneurysm. 👉 𝗣𝗿. 𝗞𝗼𝗰𝗲𝗿 continued with a complex basilar fenestration case with over 20years FU & several treatment as simple coiling / remodeling / stenting / then FD. "𝙄𝙣𝙞𝙩𝙞𝙖𝙡 𝙖𝙜𝙜𝙧𝙚𝙨𝙨𝙞𝙫𝙞𝙩𝙮 “ 𝙑𝙎 𝙗𝙖𝙡𝙖𝙣𝙘𝙚 𝙗𝙚𝙩𝙬𝙚𝙚𝙣 𝙖𝙙𝙙𝙞𝙣𝙜 𝙢𝙤𝙧𝙚 & 𝙢𝙤𝙧𝙚 𝙢𝙖𝙩𝙚𝙧𝙞𝙖𝙡 (which is possibly linked to better occlusion rates but possibly also to more complications). But aneurysm prone to recurrence probably need to be treated aggressively initially & possibly using efficient associations of devices. ➡️ 𝙈𝙤𝙧𝙚 𝙩𝙤 𝙘𝙤𝙢𝙚 𝙞𝙣 𝘽𝙐𝙎𝘼𝙉 𝙎𝙤𝙪𝙩𝙝 𝙆𝙤𝙧𝙚𝙖 2026! 💡𝐒𝐭𝐚𝐲 𝐭𝐮𝐧𝐞𝐝 𝘋𝘳. 𝘈𝘯𝘯𝘦-𝘊𝘩𝘳𝘪𝘴𝘵𝘪𝘯𝘦 𝘑𝘢𝘯𝘶𝘦𝘭 & P𝘳. 𝘑𝘦𝘢𝘯-𝘊𝘩𝘳𝘪𝘴𝘵𝘰𝘱𝘩𝘦 𝘎𝘦𝘯𝘵𝘳𝘪𝘤

#WFITN2024 #INReporters - stenting DAVFs For low grade, Type I & Type IIa, without cortical venous reflux. The 𝙜𝙤𝙖𝙡 𝙤𝙛 𝙩𝙝𝙚 𝙩𝙧𝙚𝙖𝙩𝙢𝙚𝙣𝙩 𝙞𝙨 𝙩𝙤 𝙞𝙢𝙥𝙧𝙤𝙫𝙚 𝙘𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝙛𝙪𝙣𝙘𝙩𝙞𝙤𝙣𝙖𝙡 𝙨𝙮𝙢𝙥𝙩𝙤𝙢𝙨 𝙨𝙪𝙘𝙝 𝙖𝙨 𝙩𝙞𝙣𝙣𝙞𝙩𝙪𝙨 𝙛𝙤𝙧 𝙜𝙧𝙖𝙙𝙚 𝙄 𝙤𝙧 𝙖𝙫𝙤𝙞𝙙 𝙧𝙞𝙨𝙠 𝙤𝙛 𝙄𝙣𝙩𝙧𝙖𝙘𝙧𝙖𝙣𝙞𝙖𝙡 𝙝𝙮𝙥𝙚𝙧𝙩𝙚𝙣𝙨𝙞𝙤𝙣 𝙤𝙧 𝙫𝙚𝙣𝙤𝙪𝙨 𝙙𝙚𝙢𝙚𝙣𝙩𝙞𝙖 𝙛𝙤𝙧 𝙜𝙧𝙖𝙙𝙚 𝙄𝙄. ➡️ From a physiopathological view it could make sense to stent, because it allows to restaure a good venous outflow & potentially “crash” the small veinules within the wall of the sinus (responsible for the shunt). ➡️ Stenting lateral or sigmoid sinus is easy , straightforward & in most cases will lead to a resolution of the clinical symptoms & cure of the fistula. ➡️ It occurred in some cases that a small residual fistula is still visible on FU, but type 1 without any haemorrhagic risk for the patient. Residual will be left as the goal toward resolution of tinnitus has been reached! 💡𝐒𝐭𝐚𝐲 𝐭𝐮𝐧𝐞𝐝 𝘋𝘳. 𝘈𝘯𝘯𝘦-𝘊𝘩𝘳𝘪𝘴𝘵𝘪𝘯𝘦 𝘑𝘢𝘯𝘶𝘦𝘭 & P𝘳. 𝘑𝘦𝘢𝘯-𝘊𝘩𝘳𝘪𝘴𝘵𝘰𝘱𝘩𝘦 𝘎𝘦𝘯𝘵𝘳𝘪𝘤

#WFITN2024 #INReporters - INSTANT study 👉 𝗣𝗿. 𝗣𝗶𝗲𝗿𝗼𝘁 presented results of 𝙄𝙉𝙎𝙏𝘼𝙉𝙏 : 𝙖 𝙀𝙪𝙧𝙤𝙥𝙚𝙖𝙣 𝙥𝙧𝙤𝙨𝙥𝙚𝙘𝙩𝙞𝙫𝙚 𝙢𝙪𝙡𝙩𝙞𝙘𝙚𝙣𝙩𝙧𝙞𝙘 𝙨𝙩𝙪𝙙𝙮 𝙤𝙣 𝙧𝙪𝙥𝙩𝙪𝙧𝙚𝙙 & 𝙪𝙣𝙧𝙪𝙥𝙩𝙪𝙧𝙚𝙙 𝙖𝙣𝙚𝙪𝙧𝙮𝙨𝙢𝙨 𝙩𝙧𝙚𝙖𝙩𝙚𝙙 𝙬𝙞𝙩𝙝 𝙊𝙥𝙩𝙞𝙢𝙖 𝙘𝙤𝙞𝙡𝙨. ➡️ Primary objective is safety at day 30 & secondary one is safety & efficacy at 1 year ➡️ 294 patients have been included, with 161 ruptured & 133 unruptured IA. It’s worth to mention a very extensive 12M FU (91,8%). ➡️ mostly Acom (ruptured), 17.7% MCA, below than 10mm in diameter ➡️ at one month, overall mortality 1.4% & morbidity was 10.2% (related to SAH complications) ➡️ at one year, morbidity is 2.9% & mortality is 1.8%, hemorrhagic complications ((including intraoperative rupture) occured in 2.7% & thromboembolic complications in 5.1% 👉 𝗣𝗿. 𝗣𝗶𝗲𝗿𝗼𝘁 conclusion was 𝙄𝙉𝙎𝙏𝘼𝙉𝙏 𝙨𝙝𝙤𝙬𝙨 𝙩𝙝𝙖𝙩 𝙘𝙤𝙞𝙡𝙞𝙣𝙜 𝙨𝙩𝙞𝙡𝙡 𝙧𝙚𝙢𝙖𝙞𝙣 𝙖 𝙫𝙚𝙧𝙮 𝙨𝙖𝙛𝙚 𝙩𝙚𝙘𝙝𝙣𝙞𝙦𝙪𝙚 𝙛𝙤𝙧 𝙩𝙧𝙚𝙖𝙩𝙞𝙣𝙜 𝙖𝙣𝙚𝙪𝙧𝙮𝙨𝙢𝙨. It demonstrates a slight improvement of coiling safety compared to previous studies such as ATENA or CLARITY. Still there is a need for improvement of the management of vasospasm and hydrocephalus! 💡𝐒𝐭𝐚𝐲 𝐭𝐮𝐧𝐞𝐝 𝘋𝘳. 𝘈𝘯𝘯𝘦-𝘊𝘩𝘳𝘪𝘴𝘵𝘪𝘯𝘦 𝘑𝘢𝘯𝘶𝘦𝘭 & P𝘳. 𝘑𝘦𝘢𝘯-𝘊𝘩𝘳𝘪𝘴𝘵𝘰𝘱𝘩𝘦 𝘎𝘦𝘯𝘵𝘳𝘪𝘤

#WFITN2024 #INReporters - pathophysiology Pathophysiology is likely multifactorial as risk factors are associated with the growth & rupture of intracranial aneurysms (IA) - smoking, high blood pressure, family history & risk associated with polycystic kidney, etc. 👉 𝗣𝗿. 𝗛𝗼𝗵 demonstrated how likely it involves a genetic component. ➡️ Genome wide association studies (comparing DNAs to identify genetics markers associated with a disease) identified significant association between genes 𝙎𝙊𝙓17, 𝘾𝘿𝙆𝙉2𝘽 & 𝙀𝘿𝙉𝙍𝘼 𝙚𝙣𝙙𝙤𝙩𝙝𝙚𝙡𝙞𝙣-1 𝙧𝙚𝙘𝙚𝙥𝙩𝙤𝙧 with 𝙫𝙖𝙨𝙘𝙪𝙡𝙖𝙧 𝙚𝙣𝙙𝙤𝙩𝙝𝙚𝙡𝙞𝙖𝙡 𝙢𝙖𝙞𝙣𝙩𝙚𝙣𝙖𝙣𝙘𝙚, 𝙞𝙣𝙩𝙚𝙜𝙧𝙞𝙩𝙮 𝙤𝙛 𝙩𝙝𝙚 𝙚𝙭𝙩𝙧𝙖𝙘𝙚𝙡𝙡𝙪𝙡𝙖𝙧 𝙢𝙖𝙩𝙧𝙞𝙭, 𝙞𝙣𝙛𝙡𝙖𝙢𝙢𝙖𝙩𝙞𝙤𝙣 & 𝙫𝙖𝙨𝙘𝙪𝙡𝙖𝙧 𝙙𝙞𝙨𝙚𝙖𝙨𝙚. ➡️ Epigenetic may play a role too : it’s about change in gene expression, heritable but influenced also by the environment, lifestyle, etc. (inflammation, hemodynamics & wall shear stress, estrogen deficiency. 📝 To go further https://lnkd.in/e4ZKywCs https://lnkd.in/epzp5X_A 👉 𝗗𝗿. 𝗙𝗿𝗼𝘀𝗲𝗻 gave a talk about the 𝙞𝙢𝙥𝙖𝙘𝙩 𝙤𝙛 𝙢𝙞𝙘𝙧𝙤𝙗𝙞𝙤𝙢𝙚 𝙚𝙭𝙥𝙤𝙨𝙪𝙧𝙚 𝙤𝙣 𝙩𝙝𝙚 𝙛𝙤𝙧𝙢𝙖𝙩𝙞𝙤𝙣, 𝙜𝙧𝙤𝙬𝙩𝙝 & 𝙧𝙪𝙥𝙩𝙪𝙧𝙚 𝙤𝙛 𝙄𝘼. Microbial antigens can influence aneurysm wall inflammation indirectly. Specifically oral & gut microbiome may influence the inflammation-driven aneurysm wall remodelling through different mechanisms. ➡️ It was found that current & prior periodontal disease are associated with the formation & rupture of IA, suggesting that periodontal disease might contribute to the mechanisms by which the bacteria-antigens reach the aneurysm wall 📝 To go further https://lnkd.in/eUaYTnMr https://lnkd.in/eGm8AEf9 Some families which have a predisposition to develop IA could be explained by transmission of microbiome (adding lifestyle living habits influence course). 𝘾𝙤𝙪𝙡𝙙 𝙢𝙞𝙘𝙧𝙤𝙗𝙞𝙤𝙢𝙚 𝙨𝙘𝙧𝙚𝙚𝙣𝙞𝙣𝙜 𝙗𝙚 𝙪𝙨𝙚𝙙 𝙩𝙤 𝙞𝙙𝙚𝙣𝙩𝙞𝙛𝙮 𝙥𝙚𝙧𝙨𝙤𝙣𝙖𝙡 𝙧𝙞𝙨𝙠 𝙤𝙛 𝙙𝙚𝙫𝙚𝙡𝙤𝙥𝙥𝙞𝙣𝙜 𝙄𝘼? 💡𝐒𝐭𝐚𝐲 𝐭𝐮𝐧𝐞𝐝 𝘋𝘳. 𝘈𝘯𝘯𝘦-𝘊𝘩𝘳𝘪𝘴𝘵𝘪𝘯𝘦 𝘑𝘢𝘯𝘶𝘦𝘭 & P𝘳. 𝘑𝘦𝘢𝘯-𝘊𝘩𝘳𝘪𝘴𝘵𝘰𝘱𝘩𝘦 𝘎𝘦𝘯𝘵𝘳𝘪𝘤

#WFITN2024 #INReporters 👉 𝗣𝗿. 𝗖𝗵𝗮𝗽𝗼𝘁 presented the 𝙂𝙖𝙢𝙖 𝙈𝙄𝘾𝙍𝙊𝘾𝙃𝘼𝙋 𝙢𝙞𝙘𝙧𝙤𝙘𝙖𝙩𝙝𝙚𝙩𝙚𝙧 which is a preshaped microcatheter allowing to manage angulated arteries at the level of the neck of the aneurysm. It allowed to get the difficult branch in case of wide neck & recurrent branch. The MICROCHAP is available in two types of “simmons” curves. ➡️ 𝙏𝙤𝙧𝙦𝙪𝙞𝙣𝙜 𝙘𝙖𝙧𝙚𝙛𝙪𝙡𝙡𝙮 𝙩𝙝𝙚 𝙢𝙞𝙘𝙧𝙤𝙘𝙖𝙩𝙝𝙚𝙩𝙚𝙧 𝙞𝙨 𝙩𝙝𝙚 𝙬𝙖𝙮 𝙩𝙤 𝙜𝙪𝙞𝙙𝙚 𝙩𝙝𝙞𝙨 𝙩𝙞𝙣𝙮 𝙨𝙞𝙢𝙢𝙤𝙣𝙨 𝙞𝙣 𝙩𝙝𝙚 𝙖𝙣𝙚𝙪𝙧𝙮𝙨𝙢 𝙩𝙤 𝙛𝙞𝙣𝙙 𝙩𝙝𝙚 𝙬𝙖𝙮 𝙤𝙪𝙩. ➡️ Global philosophy is to avoid turning a loop & pushing on the dome of a small aneurysm to find the recurrent branch. 👉 𝗣𝗿. 𝗖𝗵𝗮𝗽𝗼𝘁 showed impressive cases of fusiform vertebral giant aneurysm treated with long braided Leo+ stents with impressive images of stabilization of those very difficult disease. He highlighted the fact that 𝙗𝙧𝙖𝙞𝙙𝙚𝙙 𝙨𝙩𝙚𝙣𝙩𝙨 𝙧𝙚𝙥𝙧𝙚𝙨𝙚𝙣𝙩 𝙖𝙣 𝙖𝙡𝙩𝙚𝙧𝙣𝙖𝙩𝙞𝙫𝙚 𝙩𝙤 𝙛𝙡𝙤𝙬 𝙙𝙞𝙫𝙚𝙧𝙩𝙚𝙧𝙨 (FD) 𝙖𝙩 𝙚𝙖𝙧𝙡𝙮 𝙨𝙩𝙖𝙜𝙚 𝙤𝙛 𝙢𝙖𝙣𝙖𝙜𝙚𝙢𝙚𝙣𝙩 𝙤𝙛 𝙩𝙝𝙤𝙨𝙚 𝙡𝙚𝙨𝙞𝙤𝙣𝙨. Leo+ stent has less thrombogenic material compared to FD & could possibly result in less TE events. 𝗣𝗿. 𝗖𝗵𝗮𝗽𝗼𝘁 showed the use of this stent with complete or partial occlusion of those aneurysms. He also showed the potential of partial coiling of a bleb in case of rupture. ➡️ 𝙒𝙖𝙡𝙡 𝙖𝙥𝙥𝙤𝙨𝙞𝙩𝙞𝙤𝙣 𝙞𝙨 𝙠𝙚𝙮 & 𝙡𝙖𝙧𝙜𝙚 𝙙𝙚𝙫𝙞𝙘𝙚𝙨 𝙖𝙧𝙚 𝙣𝙚𝙚𝙙𝙚𝙙 𝙞𝙣 𝙩𝙝𝙚 𝙙𝙚𝙡𝙞𝙘𝙖𝙩𝙚 𝙘𝙖𝙨𝙚 𝙤𝙛 𝙙𝙚𝙘𝙞𝙨𝙞𝙤𝙣 𝙤𝙛 𝙩𝙧𝙚𝙖𝙩𝙢𝙚𝙣𝙩. 💡𝐒𝐭𝐚𝐲 𝐭𝐮𝐧𝐞𝐝 𝘋𝘳. 𝘈𝘯𝘯𝘦-𝘊𝘩𝘳𝘪𝘴𝘵𝘪𝘯𝘦 𝘑𝘢𝘯𝘶𝘦𝘭 & P𝘳. 𝘑𝘦𝘢𝘯-𝘊𝘩𝘳𝘪𝘴𝘵𝘰𝘱𝘩𝘦 𝘎𝘦𝘯𝘵𝘳𝘪𝘤

#WFITN2024 #INReporters 👉 𝗣𝗿. 𝗛𝗼𝗻𝗴𝗾𝗶 𝗭𝗵𝗮𝗻𝗴 gave an talk about 𝙫𝙚𝙣𝙤𝙪𝙨 𝙝𝙮𝙥𝙚𝙧𝙩𝙚𝙣𝙨𝙞𝙤𝙣 𝙖𝙨 𝙖 𝙥𝙤𝙨𝙨𝙞𝙗𝙡𝙚 𝙘𝙖𝙪𝙨𝙚 𝙤𝙛 𝘿𝘼𝙑𝙁. He started with the causes of DAVF formation : ➡️ Venous hypertension leads to dilatation of the vessels & loss of the sphincter control function in arterioles ➡️ Intraluminal pressure in the vessels stimulates angiogenesis ➡️ Increase in venous pressure also causes reduction of perfusion pressure resulting in tissue hypoxia ➡️ Venous hypertension leads to opening normal arteriovenous shunts in the venous sinus.  𝙒𝙝𝙮 𝙖𝙧𝙚 𝙨𝙩𝙚𝙣𝙩𝙞𝙣𝙜 𝙤𝙧 𝙖𝙣𝙜𝙞𝙤𝙥𝙡𝙖𝙨𝙩𝙮 𝙩𝙤𝙙𝙖𝙮 𝙘𝙤𝙣𝙨𝙞𝙙𝙚𝙧𝙚𝙙 𝙖𝙨 𝙩𝙧𝙚𝙖𝙩𝙢𝙚𝙣𝙩 𝙤𝙛 𝙨𝙤𝙢𝙚 𝙤𝙛 𝙩𝙝𝙚 𝘿𝘼𝙑𝙁? Especially the DAVF without cortical reflux involving the lateral sinus. 𝙄𝙨 𝙩𝙝𝙚 𝙩𝙧𝙚𝙖𝙩𝙢𝙚𝙣𝙩 𝙤𝙛 𝙩𝙝𝙚 𝙫𝙚𝙣𝙤𝙪𝙨 𝙝𝙮𝙥𝙚𝙧𝙩𝙚𝙣𝙨𝙞𝙤𝙣 𝙡𝙚𝙖𝙙𝙞𝙣𝙜 𝙩𝙤 𝙩𝙝𝙚 𝙘𝙪𝙧𝙚 𝙤𝙛 𝙩𝙝𝙚 𝙛𝙞𝙨𝙩𝙪𝙡𝙖? 𝙒𝙝𝙖𝙩 𝙞𝙨 𝙩𝙝𝙚 𝙞𝙢𝙥𝙤𝙧𝙩𝙖𝙣𝙘𝙚 𝙤𝙛 𝙩𝙝𝙚 𝙣𝙤𝙧𝙢𝙖𝙡𝙞𝙯𝙖𝙩𝙞𝙤𝙣 𝙤𝙛 𝙩𝙝𝙚 𝙫𝙚𝙣𝙤𝙪𝙨 𝙥𝙧𝙚𝙨𝙨𝙪𝙧𝙚 𝙞𝙣 𝙩𝙝𝙚 𝙝𝙚𝙖𝙡𝙞𝙣𝙜 𝙥𝙧𝙤𝙘𝙚𝙨𝙨? 👉 𝗣𝗿. 𝗠𝗼𝗿𝗲𝘁 continued the session by presenting another way of classifying the DAVF lesions. He dichotomized the pathology of the periosteum with the osteo-dural fistula type & the duro-dural fistula type & the pathology of the leptomeninges (duro-pial type and duro-arachnoidal type). The duro-pial fisula corresponds to a pathology of the peri-arterial spaces & the duro-arachnoidal type corresponds to a pathology of the peri-venous spaces. Pr. Moret considers that 𝙣𝙤𝙧𝙢𝙖𝙡𝙞𝙯𝙖𝙩𝙞𝙤𝙣 𝙤𝙛 𝙩𝙝𝙚 𝙫𝙚𝙣𝙤𝙪𝙨 𝙥𝙧𝙚𝙨𝙨𝙪𝙧𝙚 𝙞𝙨 𝙖 𝙠𝙚𝙮 𝙛𝙖𝙘𝙩𝙤𝙧 𝙞𝙣 𝙩𝙝𝙚 𝙝𝙚𝙖𝙡𝙞𝙣𝙜 𝙥𝙧𝙤𝙘𝙚𝙨𝙨. 💡𝐒𝐭𝐚𝐲 𝐭𝐮𝐧𝐞𝐝 𝘋𝘳. 𝘈𝘯𝘯𝘦-𝘊𝘩𝘳𝘪𝘴𝘵𝘪𝘯𝘦 𝘑𝘢𝘯𝘶𝘦𝘭 & P𝘳. 𝘑𝘦𝘢𝘯-𝘊𝘩𝘳𝘪𝘴𝘵𝘰𝘱𝘩𝘦 𝘎𝘦𝘯𝘵𝘳𝘪𝘤

We’re here at the 17th WFITN Congress in New York until October 10th! Come visit our booth, meet our experts, and learn about the advancements we’re bringing to neurovascular treatment. Don’t miss out! #WFITN2024